Clinical Trial: A Single-arm Observational Study to Characterize the Epidemiological Profile of Patients With IDH-mutant Diffuse Gliomas Diagnosed From 2021 in Brazil.

U.S., Aug. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07789678) titled 'A Single-arm Observational Study to Characterize the Epidemiological Profile of Patients With IDH-mutant Diffuse Gliomas Diagnosed From 2021 in Brazil.' on Aug. 24.

Brief Summary: This is a real-world, retrospective, non-interventional, single-arm, multi-center Brazilian study that will include patients diagnosed with IDH-mutant diffuse glioma in Brazil from 2021. Eligible patients will be included in this study to have their medical charts data collected by site personnel. Included patients won't be requested to attend protocol-specific visits and treatment decisions and disease management will be at the investigator's discretion ...